Wolf‐Dieter Ludwig

Escalated-Dose BEACOPP in the Treatment of Patients With Advanced-Stage Hodgkin's Lymphoma: 10 Years of Follow-Up of the GHSG HD9 Study

Andreas Engert, Volker Diehl, Jeremy Franklin et al. · Journal of Clinical Oncology · 2009 · 498 citations · Full text

Medicine, Oncology, Pharmacology +14

Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

Michael Dworzak, Giuseppe Gaipa, Richard Ratei et al. · Cytometry Part B Clinical Cytometry · 2008 · 156 citations

Medicine, Hematology, Oncology +17

<scp>AIEOP</scp>‐<scp>BFM</scp>Consensus Guidelines 2016 for Flow Cytometric Immunophenotyping of Pediatric Acute Lymphoblastic Leukemia

Michael Dworzak, Barbara Buldini, Giuseppe Gaipa et al. · Cytometry Part B Clinical Cytometry · 2017 · 147 citations · Full text

Medicine, Hematology, Oncology +14

Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.

Hans G. Drexler, E. Thiel, Wolf‐Dieter Ludwig · PubMed · 1991 · 144 citations

Medicine, Hematology, Oncology +12

Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM family” cooperative group

Anna Berg, Claus R. Bartram, Giuseppe Basso et al. · Medical and Pediatric Oncology · 1992 · 109 citations

Medicine, Hematology, Oncology +17